Managing heterogeneity in prescription drug coverage policies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24856594.
- Also identified by DOI 10.18553/jmcp.2014.20.6.564 and PMC identifier 10438339.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Necessity and fairness require that health plans limit the products and services they cover. The basis for these decisions refers to population averages and related population parameters. However, individuals vary and may not be accurately represented by the parameters used to establish coverage policies. Health plans, therefore, are obligated to anticipate and manage heterogeneity among their member groups. This commentary offers considerations for managing heterogeneity in prescription drug benefits.
Medical subject headings
- Insurance Benefits
- Insurance Coverage
- Insurance, Pharmaceutical Services
- Pharmaceutical Services
- Policy Making
- Population Groups
- Prescription Drugs